Verrica Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.60 | -$0.32 | -$0.45 |
| Q2 2024 | 1 | -$0.55 | -$0.29 | -$0.41 |
| Q3 2024 | 1 | -$0.50 | -$0.27 | -$0.38 |
| Q4 2024 | 3 | -$0.41 | -$0.21 | -$0.30 |
| Q1 2025 | 1 | -$0.27 | -$0.14 | -$0.20 |
| Q2 2025 | 1 | -$0.21 | -$0.11 | -$0.16 |
| Q3 2025 | 1 | -$0.19 | -$0.10 | -$0.14 |
| Q4 2025 | 1 | -$0.17 | -$0.09 | -$0.13 |
Verrica Pharmaceuticals Inc. Earnings Date And Information
Verrica Pharmaceuticals Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-0.49 earnings per share for the quarter, missing analysts' consensus estimates of $-0.37 by $0.12. The company had revenue of -1,781,000 for the quarter and had revenue of 5.12 M for the year. Verrica Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-1.48 diluted earnings per share) and currently has a price-to-earnings ratio of -0.49. Verrica Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
Verrica Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$0.49 | $5.26 M | $-1,781,000 | ||
| 08/14/2024 | Q2 2024 | -$0.43 | -$0.37 | 0.06 | $4.58 M | $5.18 M |
| 05/13/2024 | Q1 2024 | -$0.54 | -$0.44 | 0.1 | $3.83 M | |
| 02/29/2024 | Q4 2023 | -$0.47 | -$0.53 | -0.06 | $1.99 M | |
| 11/09/2023 | Q3 2023 | -$0.22 | -$0.54 | -0.32 | $454,068 | $2.92 M |
| 08/08/2023 | Q2 2023 | -$0.22 | -$0.24 | -0.02 | $57,600 | $182,000 |
| 05/09/2023 | Q1 2023 | -$0.20 | -$0.14 | 0.06 | $37,000 | |
| 03/06/2023 | Q4 2022 | -$0.20 | -$0.14 | 0.06 | $68,000 | |
| 11/07/2022 | Q3 2022 | -$0.11 | $0.00 | 0.11 | $4.33 M | $8.32 M |
| 08/11/2022 | Q2 2022 | -$0.32 | -$0.41 | -0.09 | $312,500 | $214,000 |
| 05/09/2022 | Q1 2022 | -$0.54 | -$0.35 | 0.19 | $431,000 | |
| 03/02/2022 | Q4 2021 | -$0.48 | -$0.35 | 0.13 | $-12,000,000 | |
| 11/12/2021 | Q3 2021 | -$0.49 | -$0.47 | 0.02 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.41 | -$0.43 | -0.02 | $200,000 | $0 |
| 05/07/2021 | Q1 2021 | -$0.35 | -$0.04 | 0.31 | $12.00 M | |
| 03/17/2021 | Q4 2020 | -$0.52 | $0 | |||
| 11/09/2020 | Q3 2020 | -$0.46 | -$0.42 | 0.04 | $0 | |
| 08/05/2020 | Q2 2020 | -$0.45 | -$0.38 | 0.07 | $0 | |
| 05/07/2020 | Q1 2020 | -$0.39 | -$0.39 | 0 | $0 | |
| 03/13/2020 | Q4 2019 | -$0.30 | -$0.31 | -0.01 | $0 |
Verrica Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is Verrica Pharmaceuticals Inc.'s earnings date?
Verrica Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
-
How can I listen to Verrica Pharmaceuticals Inc.'s earnings conference call?
The conference call for Verrica Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read Verrica Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Verrica Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does Verrica Pharmaceuticals Inc. generate each year?
Verrica Pharmaceuticals Inc. (:VRCA) has a recorded annual revenue of $5.12 M.
-
How much profit does Verrica Pharmaceuticals Inc. generate each year?
Verrica Pharmaceuticals Inc. (:VRCA) has a recorded net income of $5.12 M. Verrica Pharmaceuticals Inc. has generated $-1.48 earnings per share over the last four quarters.
-
What is Verrica Pharmaceuticals Inc.'s price-to-earnings ratio?
Verrica Pharmaceuticals Inc. (:VRCA) has a price-to-earnings ratio of -0.49 and price/earnings-to-growth ratio is -0.18.
